Why is the NEPTUNE Study important?
study
is being
done
happens
during the
study
Non-infectious uveitis (NIU) is an inflammatory eye condition with symptoms such as changes in vision, floaters, pain, redness, and swelling. NIU can significantly impact a person’s quality of life and may eventually lead to serious vision loss. Researchers continue to explore NIU and possible treatments for these individuals.
The NEPTUNE Study is evaluating a drug for adults with NIU. Pharmaceutical companies use clinical research studies like this one to learn more about study drugs before they are made available to the public. Study volunteers help us in this important research. Thank you for considering participation in this study.
Being a part of this study is up to you!
Non-infectious uveitis (NIU) is an inflammatory eye condition with symptoms such as changes in vision, floaters, pain, redness, and swelling. NIU can significantly impact a person’s quality of life and may eventually lead to serious vision loss. Researchers continue to explore NIU and possible treatments for these individuals.
The NEPTUNE Study is evaluating a drug for adults with NIU. Pharmaceutical companies use clinical research studies like this one to learn more about study drugs before they are made available to the public. Study volunteers help us in this important research. Thank you for considering participation in this study.
Being a part of this study is up to you!
happens
during the
study
The NEPTUNE Study is evaluating a drug for adults with NIU. Pharmaceutical companies use clinical research studies like this one to learn more about study drugs before they are made available to the public. Study volunteers help us in this important research. Thank you for considering participation in this study.
Being a part of this study is up to you!
What is the purpose
of the NEPTUNE Study?
safe?
work?
The NEPTUNE Study is investigating a study drug called brepocitinib to find out if it has the potential to be safe and effective in decreasing and controlling inflammation in adults with NIU.
Brepocitinib is considered a study drug because it is not yet approved by any health regulatory agency (like the US Food and Drug Administration [FDA]) for use by the general public.
Who can participate in the NEPTUNE study?
To be eligible for this study, you must be:
Between 18 and 74 years of age
Diagnosed with NIU and actively experiencing symptoms
This is not a complete list of study requirements. The study doctor will review the full requirements for this study with you.